disease-outbreaks

Documents about disease-outbreaks

• Global surveillance of anthrax outbreaks in domestic animals and humans: A retrospective secondary analysis of reported cases over two decades (2005-2024)#478544Europe PMC
• Revue intra-action (RIA) de la COVID-19 : modèle de note conceptuelle, 23 juillet 2020#649871WHO IRIS
• West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions.#9764PubMed
• Resurgence of measles in the United States: Examining the outbreak, vaccine hesitancy, and future directions.#9932PubMed
• Estimating time-varying cholera transmission and oral cholera vaccine effectiveness in Haiti and Cameroon, 2021-2023#250537Europe PMC
• Clinical management of COVID-19: living guideline, June 2025#663617WHO IRIS
• Epidemiology and phylogenomic characterization of the Clade IIb C.1 Mpox outbreak in Phnom Penh, Cambodia (2023-2024).#9728PubMed
• Opciones terapéuticas y COVID-19: orientaciones evolutivas, 10 de noviembre de 2023#356067WHO IRIS
• WHO guidelines on the use of chest imaging in COVID-19#404869WHO IRIS
• From disaster to disease : dengue outbreaks after mining dam failures in Mariana and Brumadinho, Brazil.#680420REPOSITORIO INSTITUCIONAL DA UFOP
• Framework and toolkit for infection prevention and control in outbreak preparedness, readiness and response at the national level#155918WHO IRIS
• Evaluation of varicella outbreak control following implementation of a two-dose free vaccination policy in Wuxi, China (2014-2024).#9877PubMed
• Vigilancia epidemiológica frente al virus Andes: ¿hemos aprendido algo tras la COVID-19?#294132DIALNET OAI Articles
• Planning and implementation of a community-wide tuberculosis screening intervention: a case study from Naujaat, Nunavut, Canada.#372118PubMed
• Impact of Extreme Weather Events and Land use on Leptospira Distribution in Vembanad Lake and Associated Disease Outbreaks in Near Shore Areas#387073CMFRI Digital Repository
• Managing meningitis epidemics in Africa: a quick reference guide for health authorities and health-care workers#429103WHO IRIS
• Repurposing facilities for quarantine or isolation and management of mild COVID-19 cases#649878WHO IRIS
• COVID-19 infection prevention and control living guideline: mask use in community settings, 22 December 2021#413792WHO IRIS
• A rapid, easy, and scalable whole blood monocyte CD169 assay for outpatient screening during SARS-CoV-2 outbreak, and potentially other emerging disease outbreaks#205731HAL (France)
• Fourth meeting of the Technical Advisory Group on Safe Schooling during the COVID-19 Pandemic: Copenhagen, Denmark, 9 March 2021#163837WHO IRIS
• Timing is infectious: eco-epidemiological modelling of Pteropus lylei in Cambodia suggests regular annual coronavirus outbreaks in bats#257743HAL (France)
• Search strategy for Pathogen molecular typing to inform interventions at public health, healthcare setting, and patient levels: a scoping review#435664Borealis Dataverse OAI Archive
• Food-borne salmonella outbreak at a bank cafeteria: an investigation in an Arab country in transition#649876WHO IRIS
• Topological data analysis for predicting disease outbreaks in humanitarian settings: A machine learning approach#263314PLOS
• Preliminary molecular characterization of foot-and-mouth disease virus SAT-1 topotype III associated with recent cattle outbreaks in Syria#368452PLOS
• User manual for the Member State Rapid Risk Assessment (MS-RRA) tool#663620WHO IRIS
• Clinical management and infection prevention and control for mpox: living guideline, May 2025#1068640WHO IRIS
• Regional Consultation on Vaccine and Immunization Research Preparedness for Vaccine Preventable Disease (VPD) Outbreaks and Pandemics, 14–16 April 2026, New Delhi, India#349387WHO IRIS
• Orientations évolutives concernant la prise en charge clinique de la COVID-19 : orientations évolutives, 23 novembre 2021#423687WHO IRIS
• إرشادات منظمة الصحة العالمية بشأن فعاليات التجمعات الحاشدة التي يحضرها أفراد قادمون من مناطق وُثِّق رصد فيروس بونديبوغيو فيها، أيار/ مايو 2026#349393WHO IRIS
• Accélérer la préparation et la riposte aux situations d’urgence sanitaire - plan d’action#184004WHO IRIS
• Effects of hydro-meteorological and geological disasters on vaccine-preventable disease outbreaks and routine immunisation amongst children: A scoping review#275936PLOS
• Analyses en laboratoire pour le diagnostic de la diphtérie dans les contextes de flambée épidémique : orientations provisoires, 26 janvier 2024#349391WHO IRIS
• Определение совместного мониторинга: основная концепция укрепления глобальной архитектуры обеспечения готовности, реагирования и повышения устойчивости к чрезвычайным ситуациям в области здравоохранения (HEPR)#298161WHO IRIS
• Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care#638112WHO IRIS
• Document-cadre du Fonds africain pour les urgences de santé publique : rapport du Directeur régional#129099WHO IRIS
• Infectious salmon anaemia virus (ISAV) isolated from the ISA disease outbreaks in Chile diverged from ISAV isolates from Norway around 1996 and was disseminated around 2005, based on surface glycoprotein gene sequences#260618Repositorio USS
• Genomic epidemiology unveils the dynamics and spatial corridor behind the Yellow Fever virus outbreak in Southern Brazil#336521SUNScholar
• Consideraciones sobre la vigilancia ambiental y de aguas residuales relativa al virus de la viruela símica: orientaciones provisionales, 25 de noviembre de 2024#192280WHO IRIS
• Guidance for one health field epidemiology learning evaluation and certification: a supplemental manual to the "Competencies for one health field epidemiology (COHFE) framework"#298164WHO IRIS
• La vigilancia colaborativa: definición de un concepto central del fortalecimiento de la arquitectura mundial para la preparación, respuesta y resiliencia frente a emergencias sanitarias#328622WHO IRIS
• Sustaining COVID-19 pandemic response gains in the WHO Eastern Mediterranean Region: mapping strategic opportunities and ways forward#346316WHO IRIS
• Annexes to the recommendations for use of the Biological E Limited’s Corbevax (BECOV-2) vaccine against COVID-19: grading of evidence, evidence to recommendations tables, first issued 25 September 2023#432273WHO IRIS
• Xenopus laevis skin epithelial-like cell lines, Xela DS2 and Xela VS2, are permissive to several rhabdovirus species associated with disease outbreaks in fish#287303Borealis Dataverse OAI Archive
• Introduction of the annual report Dr Ahmed Al-Mandhari Regional Director WHO Eastern Mediterranean Region to the sixty-ninth session of the WHO Regional Committee, Cairo, Egypt, 10-13 October 2022#223734WHO IRIS
• Guide technique pour la surveillance intégrée de la maladie et la riposte dans la région Africaine : Volume 3 – Section 4, 5, 6 et 7#462932WHO IRIS
• تقرير مرحلي عن القضايا الصحية التي تواجه السكان المتضررين من الكوارث وحالات الطوارئ: بما في ذلك تنفيذ اللوائح الصحية الدولية (2005) [EM/RC73/INF.DOC.2]#681703WHO IRIS
• Uso de pruebas de diagnóstico rápido de detección de antígenos del SARS-CoV-2 para el autodiagnóstico de la COVID-19: orientaciones provisionales, 9 de marzo de 2022: anexo B de la web: autodiagnóstico de la COVID-19 mediante el uso de pruebas de diagnóstico rápido de detección de antígenos: evaluación de la viabilidad entre el personal de salud y la población general en Malawi y Zimbabwe#422116WHO IRIS
• Feuille de route de l’OMS concernant l’utilisation des vaccins contre la COVID-19 dans le contexte des variants Omicron et d’une forte immunité collective : approche visant à optimiser l’impact mondial des vaccins contre la COVID-19 alors que le variant Omicron et ses sous-lignées sont les principaux variants préoccupants en circulation, compte tenu des objectifs de santé publique, de l’évolution épidémiologique et d’une immunité collective croissante, première publication : 20 octobre 2020, mise à jour : 13 novembre 2020, mise à jour : 16 juillet 2021, mise à jour : 21 janvier 2022, mise à jour : 30 mars 2023, dernière mise à jour : 10 novembre 2023#341846WHO IRIS
• Hoja de ruta de la OMS sobre el uso de las vacunas contra la COVID-19 en el contexto de la variante ómicron y de la elevada inmunidad de la población: criterio para optimizar el impacto mundial de las vacunas contra la covid-19 en un momento en que la variante ómicron y sus sublinajes son las variantes preocupantes dominantes en circulación, sobre la base de los objetivos de salud pública, las características epidemiológicas en evolución y la creciente inmunidad de la población, primera publicación: 20 de octubre de 2020, actualización: 13 de noviembre de 2020, actualización: 16 de julio de 2021, actualización: 21 de enero de 2022, actualización: 30 de marzo de 2023, actualización: 10 de noviembre de 2023#341849WHO IRIS